Ardsley Advisory Partners’s RAPT Therapeutics RAPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-62,500	Closed	-$1.53M	–	145
2024 Q2	$1.53M	Buy	62,500 +12,187	+24%	+$297K	0.22%	71
2024 Q1	$3.61M	Buy	+50,313	New	+$3.61M	0.52%	54